Evidence map›Paper›PMID 28299574›Full record

ReviewMolecular neurobiology2018

Physiological and Pathological Roles of 15-Deoxy-Δ

Tatsurou Yagami, Yasuhiro Yamamoto, Hiromi Koma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Human cytomegalovirus induces neuronal enolase to support virally mediated metabolic remodeling.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. 15-deoxy-ΔBiochemistry and biophysics reports · 2019
    Article
  15. Review
  16. 15-deoxy-ΔCommunications biology · 2019
    Article
  17. Article
  18. 15d-PGJ2 is a new hope for controlling tumor growth.American journal of translational research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tatsurou YagamiDivision of Physiology, Department of Pharmaceutical Health Care, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Himeji, Hyogo, Japan. yagami@himeji-du.ac.jp.
Yasuhiro YamamotoDivision of Physiology, Department of Pharmaceutical Health Care, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Himeji, Hyogo, Japan.
Hiromi KomaDivision of Physiology, Department of Pharmaceutical Health Care, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Himeji, Hyogo, Japan.

Funding

Grants in Aid for Scientific Research from the Japan Society for the Promotion of Science 16K18892
6 · The paper itself

Abstract

Prostaglandins (PGs) are divided into conventional PGs, e.g., PGD

Indexed as

AnimalsCell SurvivalCentral Nervous SystemHumansImmunologic FactorsNervous System DiseasesNeuronsProstaglandin D215-deoxy-delta(12,14)-prostaglandin J2Immunologic FactorsProstaglandin D215-Deoxy-Δ12,14 prostaglandin J2Neuronal membrane targetsPeroxysome proliferator-activated receptor-γPhosphoinositide 3-kinaseUbiquitin proteasome pathway

Identifiers

PMID28299574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.